Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Bishop

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Journal of Clinical Microbiology|November 18, 1998
Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stem cell transplantationP C Iwen, M E Rupp, M R Bishop, et al.
Bone Marrow Transplantation|June 1, 1996
Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignanciesJ M Vose, P J Bierman, E Ruby, et al.
Progress in Clinical and Biological Research|January 1, 1994
Kinetics of low and high dose granulocyte/macrophage colony stimulating factor mobilization of peripheral blood stem cellsJ D Jackson, B Letheby, B O'Kane Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantationM R Bishop, S R Tarantolo, Z S Pavletic, et al.
Bone Marrow Transplantation|October 1, 1996
Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donorsM R Bishop, P J Henslee-Downey, J R Anderson, et al.
Seminars in Hematology|April 1, 1994
Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study GroupJ M Vose, J R Anderson, P J Bierman, et al.
Bone Marrow Transplantation|July 28, 2010
EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCTS Jamshed, D H Fowler, S S Neelapu, et al.
Progress in Clinical and Biological Research|January 1, 1994
Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemiaM R Bishop, P I Warkentin, J D Jackson, et al.
Bone Marrow Transplantation|June 6, 2006
Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantationM F Bevans, S Marden, N K Leidy, et al.
Journal of Hematotherapy & Stem Cell Research|May 17, 2000
Pharmacokinetics and in vivo effects of a six-base phosphorothioate oligodeoxynucleotide with anticancer and hematopoietic activities in swineJ E Mata, J D Jackson, S S Joshi, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Journal of Clinical Microbiology|November 18, 1998
Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stem cell transplantationP C Iwen, M E Rupp, M R Bishop, et al.
Bone Marrow Transplantation|June 1, 1996
Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignanciesJ M Vose, P J Bierman, E Ruby, et al.
Progress in Clinical and Biological Research|January 1, 1994
Kinetics of low and high dose granulocyte/macrophage colony stimulating factor mobilization of peripheral blood stem cellsJ D Jackson, B Letheby, B O'Kane Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantationM R Bishop, S R Tarantolo, Z S Pavletic, et al.
Bone Marrow Transplantation|October 1, 1996
Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donorsM R Bishop, P J Henslee-Downey, J R Anderson, et al.
Seminars in Hematology|April 1, 1994
Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study GroupJ M Vose, J R Anderson, P J Bierman, et al.
Bone Marrow Transplantation|July 28, 2010
EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCTS Jamshed, D H Fowler, S S Neelapu, et al.
Progress in Clinical and Biological Research|January 1, 1994
Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemiaM R Bishop, P I Warkentin, J D Jackson, et al.
Bone Marrow Transplantation|June 6, 2006
Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantationM F Bevans, S Marden, N K Leidy, et al.
Journal of Hematotherapy & Stem Cell Research|May 17, 2000
Pharmacokinetics and in vivo effects of a six-base phosphorothioate oligodeoxynucleotide with anticancer and hematopoietic activities in swineJ E Mata, J D Jackson, S S Joshi, et al.
Pageof 8